Subscribe to Newsletter

Superior Determination of HPV using RNAscope™ In Situ Hybridization

HPV has been identified as a causal agent in oropharyngeal squamous cell carcinoma (OPSCC) with the incidence of HPV-related OPSCC increasing dramatically over the last several decades. As patients with HPV-positive OPSCC have a significantly better survival compared to patients with HPV-negative OPSCC, testing for HPV status is critical.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Enabling Efficient, Cost-effective Sequencing of the Human Whole Exome

| Contributed by Revvity

The next generation of advanced staining

| Contributed by Sakura

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register